Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: Canada Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20052
20061
20082
20091
20101
20121
20142
20161
20171
20201
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Not yet recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AHS Cancer Control Alberta4
National Cancer Institute (NCI)3
Alliance for Clinical Trials in Oncology2
British Columbia Cancer Agency2
Bristol-Myers Squibb1
Centre hospitalier de l'Université de Montréal (CHUM)1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Merck Sharp & Dohme LLC1
Millennium Pharmaceuticals, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma21
Lung Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms2
Carcinoma, Small Cell2
Brain Neoplasms1
Carcinoma1
Carcinoma, Neuroendocrine1
Esthesioneuroblastoma, Olfactory1
Head and Neck Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.